Schizophrenia.com
Minerva Neurosciences Announces Results From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia
News
everhopeful
May 29, 2020, 2:32pm
2
Too late jamesbond! I beat you to it !
2 Likes
show post in topic
Related topics
Topic
Replies
Views
Activity
Minerva Neurosciences Announces the Results of the Phase 3 Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
News
6
321
May 12, 2021
Minerva Neurosciences (NERV) Announces MIN-101 Phase 2b Met Primary Endpoint in Schizophrenia
News
6
771
May 26, 2016
Minerva Neurosciences Announces Completion of Patient Screening in Phase 3 Trial of Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
News
0
347
January 6, 2020
Results of phase 3 trial for rouliperidone
News
6
348
May 30, 2021
Minerva neurosciences reports update on roluperidone for treatment of negative symptoms of schizophrenia
News
5
726
September 6, 2022